Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MRI Compared to Invasive Assessment: Can MRI and Echocardiography Predict the Pharmacological Response of Non-selective Beta-blocker in Patients With Cirrhosis?

NCT03438916 is registered in ClinicalTrials.gov with Hvidovre University Hospital as lead sponsor.

NCT NCT03438916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03438916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MRI Compared to Invasive Assessment: Can MRI and Echocardiography Predict the Pharmacological Response of Non-selective Beta-blocker in Patients With Cirrhosis?
Lead sponsor
Hvidovre University Hospital
Phase
Observational
Overall status
Completed
Start date
April 1, 2017
Completion date
December 8, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, esophageal varices, gastric varices bleeding, liver cirrhosis, liver diseases, portal hypertension, varice bleed